DataSheet1_Key Determinants of Health-Related Quality of Life Among Advanced Lung Cancer Patients: A Qualitative Study in Belgium and Italy.docx

Background: The lung cancer (LC) treatment landscape has drastically expanded with the arrival of immunotherapy and targeted therapy. This new variety of treatment options, each with its own characteristics, raises uncertainty regarding the key aspects affecting patients’ health-related quality of life (HRQL). The present qualitative study aimed to investigate how LC patients perceive their HRQL and the factors that they consider to be most influential in determining their HRQL. Methods: This qualitative research incorporates four focus group discussions, with six LC patients in each group. In... Mehr ...

Verfasser: Rosanne Janssens
Reinhard Arnou
Elise Schoefs
Serena Petrocchi
Clizia Cincidda
Giulia Ongaro
Serena Oliveri
Meredith Y. Smith
Evelyne Louis
Marie Vandevelde
Kristiaan Nackaerts
Gabriella Pravettoni
Isabelle Huys
Dokumenttyp: Dataset
Erscheinungsdatum: 2021
Schlagwörter: Pharmacology / Basic Pharmacology / Clinical Pharmacology and Therapeutics / Clinical Pharmacy and Pharmacy Practice / Pharmaceutical Sciences / Pharmacogenomics / Toxicology (incl. Clinical Toxicology) / Pharmacology and Pharmaceutical Sciences not elsewhere classified / patient preferences / lung cancer / health-related quality of life / qualitative research / focus group discussions / patient-reported outcome (PRO) / drug development / patient-relevant treatment outcomes
Sprache: unknown
Permalink: https://search.fid-benelux.de/Record/base-26613959
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3389/fphar.2021.710518.s001